LOGROSCINO, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 29.873
AS - Asia 12.392
EU - Europa 8.800
SA - Sud America 2.901
AF - Africa 770
OC - Oceania 171
Continente sconosciuto - Info sul continente non disponibili 22
Totale 54.929
Nazione #
US - Stati Uniti d'America 29.408
SG - Singapore 4.370
CN - Cina 2.339
BR - Brasile 2.281
HK - Hong Kong 1.771
RU - Federazione Russa 1.627
IT - Italia 1.112
DE - Germania 1.088
SE - Svezia 1.054
FR - Francia 820
GB - Regno Unito 793
FI - Finlandia 690
VN - Vietnam 687
UA - Ucraina 617
IN - India 600
BD - Bangladesh 329
IR - Iran 241
CA - Canada 238
ID - Indonesia 220
TR - Turchia 219
NL - Olanda 211
AR - Argentina 207
IQ - Iraq 203
PK - Pakistan 203
KR - Corea 195
JP - Giappone 159
IE - Irlanda 151
ZA - Sudafrica 146
AU - Australia 142
TW - Taiwan 135
BE - Belgio 116
MX - Messico 116
MY - Malesia 115
SA - Arabia Saudita 110
EC - Ecuador 109
CI - Costa d'Avorio 102
CO - Colombia 93
PH - Filippine 87
PL - Polonia 78
AT - Austria 77
MA - Marocco 75
ES - Italia 70
EG - Egitto 69
UZ - Uzbekistan 66
ET - Etiopia 64
VE - Venezuela 62
AE - Emirati Arabi Uniti 49
TN - Tunisia 49
CH - Svizzera 48
NG - Nigeria 48
CL - Cile 45
KE - Kenya 44
IL - Israele 35
NO - Norvegia 34
DZ - Algeria 33
TH - Thailandia 32
PY - Paraguay 30
RO - Romania 29
JM - Giamaica 28
JO - Giordania 28
NP - Nepal 28
NZ - Nuova Zelanda 28
GH - Ghana 27
UY - Uruguay 27
PT - Portogallo 25
AZ - Azerbaigian 24
PE - Perù 24
CR - Costa Rica 23
CZ - Repubblica Ceca 23
RS - Serbia 19
BO - Bolivia 18
KZ - Kazakistan 17
LT - Lituania 17
OM - Oman 17
LB - Libano 15
AL - Albania 13
DK - Danimarca 13
BW - Botswana 12
GR - Grecia 12
PA - Panama 12
SN - Senegal 12
BG - Bulgaria 11
KG - Kirghizistan 11
BN - Brunei Darussalam 9
EU - Europa 9
GA - Gabon 9
GE - Georgia 9
KW - Kuwait 9
LY - Libia 9
NI - Nicaragua 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
PS - Palestinian Territory 8
SY - Repubblica araba siriana 8
LK - Sri Lanka 7
LU - Lussemburgo 7
TT - Trinidad e Tobago 7
XK - ???statistics.table.value.countryCode.XK??? 7
ZM - Zambia 7
Totale 54.763
Città #
Fairfield 3.662
Ashburn 2.930
Woodbridge 2.452
Singapore 2.425
Houston 2.017
Chandler 1.934
Hong Kong 1.572
Seattle 1.538
San Jose 1.470
Jacksonville 1.362
Cambridge 1.285
Wilmington 1.177
Ann Arbor 916
Nyköping 730
Beijing 627
Dallas 565
Lawrence 445
Roxbury 435
Lauterbourg 418
New York 401
Nanjing 351
Helsinki 325
Los Angeles 312
Des Moines 307
Boardman 193
Ho Chi Minh City 193
Santa Clara 179
Munich 175
São Paulo 174
Bari 165
San Diego 149
Brooklyn 148
Hanoi 141
Council Bluffs 138
Dublin 136
Princeton 135
London 129
Paris 110
Abidjan 101
Buffalo 100
Dearborn 100
Jakarta 99
Frankfurt am Main 96
Nanchang 96
Brussels 93
Tokyo 93
Chicago 88
Shenyang 88
Dong Ket 86
Hebei 83
Inglewood 78
Jiaxing 77
Rio de Janeiro 75
Baghdad 74
Kuala Lumpur 74
Nuremberg 73
Dhaka 69
Falkenstein 69
Milan 68
The Dalles 67
Moscow 61
Tianjin 61
Central 60
Orem 60
San Francisco 59
Tashkent 58
Chennai 57
Manchester 55
Changsha 54
Columbus 54
Istanbul 52
Johannesburg 52
Tehran 51
Toronto 51
Warsaw 51
Taranto 50
Belo Horizonte 49
Taipei 47
Washington 47
Quito 46
Brasília 45
Guangzhou 45
Norwalk 45
Pune 45
Redwood City 45
Rome 45
Stockholm 45
Lahore 44
Riyadh 44
Mumbai 43
Phoenix 43
Jeddah 42
Montreal 42
Atlanta 41
Hyderabad 41
Melbourne 41
Shanghai 41
Mexico City 38
Neunburg vorm Wald 38
Ruvo Di Puglia 38
Totale 35.594
Nome #
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 3.847
Cigarette smoking and the progression of multiple sclerosis 702
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 501
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 352
Answer to "Social cognition assessment for mild neurocognitive disorders" 325
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 271
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 241
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 235
Plasma β-amyloid 1–42 reference values in cognitively normal subjects 227
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 226
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 215
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 214
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 214
A Preliminary Study on Augmenting Neuroimaging data using a Diffusion Model 213
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid 1–42 measurement 212
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 209
Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease. Alzheimer's Disease. 209
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 200
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 200
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 196
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 195
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 195
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 193
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial 191
COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis 191
Epidemiology of age related hearing loss: A review 190
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 186
Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis 186
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 184
Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects 181
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 180
A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy 180
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 180
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 178
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 177
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort 176
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 175
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy 174
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 173
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 170
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 169
The age-related central auditory processing disorder: Silent impairment of the cognitive ear 168
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 167
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 167
Epidemiology of neurodegenerative diseases 167
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 166
Bioelectrical correlates of emotional changes induced by environmental sound and colour: from virtual reality to real life 166
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 165
Classification of healthy subjects and Alzheimer's disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks 165
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 165
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 161
A Machine Learning Approach to Parkinson's Disease Blood Transcriptomics 160
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres 159
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 159
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 159
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 158
Cognitive frailty: a potential target for secondary prevention of dementia 158
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 158
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 158
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 156
Factors predicting survival in ALS: a multicenter Italian study 156
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 156
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition in Older Age 154
Age-specific ALS incidence: a dose–response meta-analysis 154
Retinal Vascular Density on Optical Coherence Tomography Angiography and Age-related Central and Peripheral Hearing Loss in a Southern Italian Older Population 154
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 153
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 153
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 153
Bipolar disorder and frontotemporal dementia: An intriguing association 152
Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis 151
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 150
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 149
Unreported financial disclosures in a study of migraine and cardiovascular disease 148
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 147
Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: A case report 146
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 145
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 144
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 144
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 144
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 143
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 143
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: Clinical validity and psychometric properties 143
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 142
Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies 142
Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy 142
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 139
Age-Related Central Auditory Processing Disorder, MCI, and Dementia in an Older Population of Southern Italy 139
Response to Letter to the Editor: “Plasma β-amyloid1–42 reference values” 138
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 137
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis 137
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 137
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 137
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 136
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 136
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 136
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 135
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke 134
Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk 134
Nutrition, frailty, and Alzheimer's disease. 133
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 133
Totale 21.664
Categoria #
all - tutte 211.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 0 0 0 0 0 317
2021/20222.928 148 177 21 133 158 340 77 156 243 211 434 830
2022/20234.752 722 468 304 427 563 548 96 574 803 38 133 76
2023/20244.501 348 629 357 335 425 1.095 484 440 88 44 51 205
2024/20258.576 250 224 905 474 255 822 704 685 363 451 1.160 2.283
2025/202615.353 2.368 544 1.194 1.540 1.522 1.037 2.004 625 2.256 1.551 703 9
Totale 56.394